Baystate Medical Center (UMass Chan-Baystate)
Obstetrics and Gynecology residency · Springfield, MA · Program website
Roster not collected yet. There's no list of this program's own faculty, trainees, or papers yet. Below is Baystate Medical Center's research in obstetrics and gynecology, which the program shares with other departments and affiliated hospitals.
About Baystate Medical Centerinstitution-wide obstetrics and gynecology research
Obstetrics and Gynecology publications from Baystate Medical Center and affiliated institutions, since 2022. Updated 2026-11-07; refreshed daily.
4
works per year
70th of 81 obstetrics and gynecology residency programs
+140.0%
2-year growth
2nd of 80 obstetrics and gynecology residency programs
few papers
in top 10% of field (works before 2025)
few papers
cited above world average
Works per year · * 2026 so far
Obstetrics and Gynecology · 19Reproductive Medicine · 1
Obstetrics and Gynecology research topics at Baystate Medical Center
Papers in the window; each links to the list on OpenAlex.
Most cited at Baystate Medical Center since 2024
All obstetrics and gynecology papers there on OpenAlex
- A randomized, phase III study of sacituzumab govitecan versus treatment of the physician’s choice in patients with endometrial cancer after platinum-based chemotherapy and immunotherapy: the ASCENT-GYN-01 study (GOG-3104/ENGOT-en26/APGOT-EN2)Ramez Nassef Eskander et al. · International Journal of Gynecological Cancer · 2025 · PubMed · cited 7
- NRG-GY037: A phase III randomized trial of induction chemotherapy and pembrolizumab followed by chemoradiation and pembrolizumab maintenance versus standard chemoradiation and pembrolizumab maintenance in high-risk locally advanced cervical cancer.Jyoti Mayadev et al. · Journal of Clinical Oncology · 2026 · cited 2
- Updated duration of response for patients receiving dostarlimab plus carboplatin-paclitaxel treatment compared with patients receiving placebo plus carboplatin-paclitaxel in the ENGOT-EN6-NSGO/GOG-3031/RUBY trialMansoor Mirza et al. · Gynecologic Oncology · 2025 · cited 1
- Racial Disparities in Surgical Treatment of Uterine Fibroids During the COVID-19 PandemicRebecca Barbaresso et al. · Journal of Women s Health · 2024 · PubMed · cited 1
- 633 Time to deterioration of patient-reported outcomes in patients with primary advanced or recurrent endometrial cancer treated with dostarlimab plus chemotherapy compared with chemotherapy in the ENGOT-EN6-NSGO/GOG-3031/RUBY trialIngrid A Boere et al. · International Journal of Gynecological Cancer · 2024 · cited 1
- SUSTAINED REMISSION AND LONG-TERM SURVIVAL OUTCOMES WITH DOSTARLIMAB PLUS CHEMOTHERAPY IN PATIENTS WITH MISMATCH REPAIR DEFICIENT/MICROSATELLITE INSTABILITY-HIGH PRIMARY ADVANCED/RECURRENT ENDOMETRIAL CANCER IN THE ENGOT-EN6-NSGO/GOG-3031/RUBY TRIALVladyslav S. Sukhin et al. · International Journal of Gynecological Cancer · 2026
- 71RO Sustained remission and long-term survival outcomes with dostarlimab plus chemotherapy in patients with dMMR/MSI-H primary advanced or recurrent endometrial cancer in the ENGOT-EN6-NSGO/GOG-3031/RUBY trialV.S. Sukhin et al. · ESMO Open · 2026
- REAL-WORLD TREATMENT PATTERNS AND OUTCOMES IN PATIENTS DIAGNOSED WITH ADVANCED ENDOMETRIAL CANCER TREATED WITH IMMUNO-ONCOLOGY THERAPIES IN THE UNITED STATES: 2019-2024Bradley R. Corr et al. · International Journal of Gynecological Cancer · 2025
- 40 Giant Cystic Adenomatoid Tumor of the Uterus: A Comprehensive Case Study of Uncommon Presentation of 15 cm Tumor with Predominant Cystic Growth PatternFnu Poombal et al. · American Journal of Clinical Pathology · 2025
- Association Between Maternal Preeclampsia and Abnormal Estimated Glomerular Filtration Rate in Adolescent Offspring Born Extremely PretermKeia Sanderson et al. · Journal of the American Society of Nephrology · 2025